Your browser doesn't support javascript.
loading
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee, Kyoo-Hyung; Lee, Je-Hwan; Lee, Jung-Hee; Kim, Dae-Young; Park, Han-Seung; Choi, Eun-Ji; Ko, Sun-Hye; Seol, Miee; Lee, Young-Shin; Kang, Young-A; Jeon, Mijin; Baek, Seunghyun; Kang, You-Lee; Kim, Sung-Han; Yun, Sung-Cheol; Kim, Hawk; Jo, Jae-Cheol; Choi, Yunsuk; Joo, Young-Don; Lim, Sung-Nam.
Afiliação
  • Lee KH; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea. Electronic address: khlee2@amc.seoul.kr.
  • Lee JH; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Lee JH; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Kim DY; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Park HS; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Choi EJ; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Ko SH; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Seol M; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Lee YS; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Kang YA; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Jeon M; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Baek S; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Kang YL; Section of Hematology, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Kim SH; Section of Infectious Diseases, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Yun SC; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
  • Kim H; Division of Hematology and Cellular Therapy, Ulsan University Hospital, College of Medicine, University of Ulsan, Ulsan, Republic of Korea.
  • Jo JC; Division of Hematology and Cellular Therapy, Ulsan University Hospital, College of Medicine, University of Ulsan, Ulsan, Republic of Korea.
  • Choi Y; Division of Hematology and Cellular Therapy, Ulsan University Hospital, College of Medicine, University of Ulsan, Ulsan, Republic of Korea.
  • Joo YD; Hematology-Oncology, Department of Internal Medicine, Haeundae Paik Hospital, College of Medicine, Inje University, Busan, Republic of Korea.
  • Lim SN; Hematology-Oncology, Department of Internal Medicine, Haeundae Paik Hospital, College of Medicine, Inje University, Busan, Republic of Korea.
Biol Blood Marrow Transplant ; 23(9): 1555-1566, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28552421
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Bussulfano / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro / Imunossupressores / Mieloma Múltiplo / Soro Antilinfocitário Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Bussulfano / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro / Imunossupressores / Mieloma Múltiplo / Soro Antilinfocitário Idioma: En Ano de publicação: 2017 Tipo de documento: Article